﻿<?xml version="1.0" encoding="utf-8"?><!--RSS Generated by www.ashp.org on Thu, 04 Dec 2008 16:24:10--><rss version="2.0"><channel><title>ASHP Health-System Pharmacy News</title><link>http://www.ashp.org/rss/news/</link><description>ASHP Health-System Pharmacy News</description><language>en-us</language><copyright>Copyright2008 ASHP</copyright><docs>http://blogs.law.harvard.edu/tech/rss/</docs><lastBuildDate>Thu, 04 Dec 2008 16:24:10</lastBuildDate><image><url>http://www.ashp.org/images/ashprss.gif</url><title>ASHP</title><link>http://www.ashp.org/</link><width>57</width><height>34</height></image><item><title><![CDATA[Tinzaparin Ups Death Risk for Some Elderly Patients, FDA Says]]></title><link>http://www.ashp.org/import/news/HealthSystemPharmacyNews/newsarticle.aspx?id=2981</link><description><![CDATA[A preliminary review of data from a European clinical trial has prompted FDA to warn that tinzaparin may be deadly for patients with impaired kidney function who are 70 years or older.]]></description><category>ASHPNews</category><author>Kate Traynor</author><guid isPermaLink="false">http://www.ashp.org/import/news/HealthSystemPharmacyNews/newsarticle.aspx?id=2981</guid><pubDate>Wed, 03 Dec 2008</pubDate></item><item><title><![CDATA[FDA Approves Plant-Derived Estrogen Cream]]></title><link>http://www.ashp.org/import/news/HealthSystemPharmacyNews/newsarticle.aspx?id=2980</link><description><![CDATA[Barr Pharmaceuticals Inc. announced today that FDA approved the marketing of SCE-A Vaginal Cream for the treatment of moderate to severe vaginal dryness and pain with intercourse.]]></description><category>ASHPNews</category><author>Cheryl A. Thompson</author><guid isPermaLink="false">http://www.ashp.org/import/news/HealthSystemPharmacyNews/newsarticle.aspx?id=2980</guid><pubDate>Mon, 01 Dec 2008</pubDate></item><item><title><![CDATA[Hospitals’ Outpatient Drug Costs Receive Increased Scrutiny]]></title><link>http://www.ashp.org/import/news/HealthSystemPharmacyNews/newsarticle.aspx?id=2979</link><description><![CDATA[In finalizing the hospital outpatient prospective payment system for 2009, the Centers for Medicare and Medicaid Services (CMS) modified the formula behind the payment rate for certain medications.]]></description><category>AJHP</category><author>Cheryl A. Thompson</author><guid isPermaLink="false">http://www.ashp.org/import/news/HealthSystemPharmacyNews/newsarticle.aspx?id=2979</guid><pubDate>Mon, 24 Nov 2008</pubDate></item><item><title><![CDATA[Drug Developers Aim To Treat Cystic Fibrosis Through Disease Modification]]></title><link>http://www.ashp.org/import/news/HealthSystemPharmacyNews/newsarticle.aspx?id=2978</link><description><![CDATA[Patients with cystic fibrosis commonly live into their teens, thanks to advances in disease management, but clinicians still cannot prescribe a treatment that addresses the underlying genetic problem.]]></description><category>AJHP</category><author>Cheryl A. Thompson</author><guid isPermaLink="false">http://www.ashp.org/import/news/HealthSystemPharmacyNews/newsarticle.aspx?id=2978</guid><pubDate>Mon, 24 Nov 2008</pubDate></item><item><title><![CDATA[Antiinfluenza Medication Kits Need Work, FDA Advisers Conclude]]></title><link>http://www.ashp.org/import/news/HealthSystemPharmacyNews/newsarticle.aspx?id=2977</link><description><![CDATA[A proposal to let Americans stockpile prescription antiviral medication in their homes in advance of an influenza pandemic drew a lukewarm response from a panel of experts convened by FDA.]]></description><category>AJHP</category><author>Kate Traynor</author><guid isPermaLink="false">http://www.ashp.org/import/news/HealthSystemPharmacyNews/newsarticle.aspx?id=2977</guid><pubDate>Mon, 24 Nov 2008</pubDate></item><item><title><![CDATA[Pharmacists Provide Academic Detailing to South Carolina Health Care Providers]]></title><link>http://www.ashp.org/import/news/HealthSystemPharmacyNews/newsarticle.aspx?id=2976</link><description><![CDATA[Faced with rising drug costs for mental health, cancer, and AIDS treatment efforts, officials with South Carolina&#8217;s Medicaid program sought ways to control these expenses.
State laws prohibit the creation of preferred drug lists in these treatment areas, so public health leaders decided to test an academic detailing program to help guide prescribing, said Jeff Stensland, a spokesperson for the South Carolina Department of Health and Human Services.]]></description><category>AJHP</category><author>Greg Lavine</author><guid isPermaLink="false">http://www.ashp.org/import/news/HealthSystemPharmacyNews/newsarticle.aspx?id=2976</guid><pubDate>Mon, 24 Nov 2008</pubDate></item><item><title><![CDATA[FDA Approves Tapentadol As Pain Reliever]]></title><link>http://www.ashp.org/import/news/HealthSystemPharmacyNews/newsarticle.aspx?id=2975</link><description><![CDATA[Johnson &amp; Johnson Pharmaceutical Research and Development LLC announced today that FDA approved the marketing of tapentadol immediate-release tablets for the relief of moderate to severe acute pain in adults.]]></description><category>ASHPNews</category><author>Cheryl A. Thompson</author><guid isPermaLink="false">http://www.ashp.org/import/news/HealthSystemPharmacyNews/newsarticle.aspx?id=2975</guid><pubDate>Fri, 21 Nov 2008</pubDate></item><item><title><![CDATA[Animas Insulin Pumps May Have Defective Battery Cap]]></title><link>http://www.ashp.org/import/news/HealthSystemPharmacyNews/newsarticle.aspx?id=2974</link><description><![CDATA[A defective battery cap may cause Animas 2020, IR 1200, and IR 1250 insulin infusion pumps to temporarily lose power and not deliver medication, the company and FDA announced this week.]]></description><category>ASHPNews</category><author>Cheryl A.Thompson</author><guid isPermaLink="false">http://www.ashp.org/import/news/HealthSystemPharmacyNews/newsarticle.aspx?id=2974</guid><pubDate>Fri, 21 Nov 2008</pubDate></item><item><title><![CDATA[Promacta Approved for Blood Disorder]]></title><link>http://www.ashp.org/import/news/HealthSystemPharmacyNews/newsarticle.aspx?id=2973</link><description><![CDATA[Eltrombopag, an oral agent that increases platelet production, was approved this week as second-line therapy for the treatment of chronic idiopathic thrombocytopenic purpura (ITP).]]></description><category>ASHPNews</category><author>Kate Traynor</author><guid isPermaLink="false">http://www.ashp.org/import/news/HealthSystemPharmacyNews/newsarticle.aspx?id=2973</guid><pubDate>Fri, 21 Nov 2008</pubDate></item><item><title><![CDATA[New Option Approved for Treating Severe Type of Epilepsy]]></title><link>http://www.ashp.org/import/news/HealthSystemPharmacyNews/newsarticle.aspx?id=2972</link><description><![CDATA[Eisai Corporation of North America announced November 14 that FDA approved the marketing of rufinamide, or Banzel, as an add-on therapy in treating seizures associated with Lennox-Gastaut syndrome in patients 4 years or older.]]></description><category>ASHPNews</category><author>Cheryl A. Thompson</author><guid isPermaLink="false">http://www.ashp.org/import/news/HealthSystemPharmacyNews/newsarticle.aspx?id=2972</guid><pubDate>Mon, 17 Nov 2008</pubDate></item></channel></rss>